Plasma Therapy Market (By Source: Allogenic, Autologous; By Type: Leukocyte-Rich Fibrin, Pure Platelet-Rich Fibrin, Leukocyte-Rich Prp, Pure Prp; By Application: Orthopaedics [Arthiritis, Bone Repair and Regeneration, Chronic Tendinitis], Cardiac Muscle Injury, Dermatology [Androgenic Alopecia, Plastic Surgery, Dental], Nerve Injury, Others; By End USer: Hospitals and Clinics, Research Institutes, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 – 2027

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 190

Table Of Content:

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
   1.1.1. Definition of Plasma Therapy
   1.1.2. Market Segmentation
   1.1.3. List of Abbreviations
1.2. Summary
   1.2.1. Market Snapshot
   1.2.2. Plasma Therapy Market By Source
     1.2.2.1. Global Plasma Therapy Market Revenue and Growth Rate Comparison By Source (2020-2027)
     1.2.2.2. Global Plasma Therapy Market Revenue Share By Source in 2019
     1.2.2.3. Allogenic
     1.2.2.4. Autologous
   1.2.3. Plasma Therapy Market By Type
     1.2.3.1. Global Plasma Therapy Market Revenue and Growth Rate Comparison By Type (2020-2027)
       1.2.3.1.1. Leukocyte-Rich Fibrin
       1.2.3.1.2. Pure Platelet-Rich Fibrin
       1.2.3.1.3. Leukocyte-Rich Prp
       1.2.3.1.4. Pure Prp
   1.2.4. Plasma Therapy Market By Application
     1.2.4.1. Global Plasma Therapy Market Revenue and Growth Rate Comparison By Application (2020-2027)
     1.2.4.2. Orthopaedics
       1.2.4.2.1. Arthiritis
       1.2.4.2.2. Bone Repair and Regeneration
       1.2.4.2.3. Chronic Tendinitis
     1.2.4.3. Cardiac Muscle Injury
     1.2.4.4. Dermatology
       1.2.4.4.1. Androgenic Alopecia
       1.2.4.4.2. Plastic Surgery
       1.2.4.4.3. Dental
     1.2.4.5. Nerve Injury
     1.2.4.6. Others
   1.2.5. Plasma Therapy Market By End USer
     1.2.5.1. Global Plasma Therapy Market Revenue and Growth Rate Comparison By End USer (2020-2027)
     1.2.5.2. Hospitals and Clinics
     1.2.5.3. Research Institutes
     1.2.5.4. Others
   1.2.6. Plasma Therapy Market By Geography
     1.2.6.1. Global Plasma Therapy Market Revenue and Growth Rate Comparison by Geography (2020-2027)
     1.2.6.2. North America Plasma Therapy Market Revenue and Growth Rate(2020-2027)
     1.2.6.3. Europe Plasma Therapy Market Revenue and Growth Rate(2020-2027)
     1.2.6.4. Asia-Pacific Plasma Therapy Market Revenue and Growth Rate(2020-2027)
     1.2.6.5. Latin America Plasma Therapy Market Revenue and Growth Rate(2020-2027)
     1.2.6.6. Middle East and Africa (MEA) Plasma Therapy Market Revenue and Growth Rate(2020-2027)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
   2.4.1. Bargaining Power of Suppliers
   2.4.2. Bargaining Power of Buyers
   2.4.3. Threat of Substitute
   2.4.4. Threat of New Entrants
   2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
   2.6.1. Raw Material and Suppliers
   2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2019
   2.8.1. Player Positioning Analysis
   2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Plasma Therapy Major Manufacturers in 2019
3.2. Manufacturing Plants Distribution of Global Plasma Therapy Major Manufacturers in 2019
3.3. R&D Status and Technology Source of Global Plasma Therapy Major Manufacturers in 2019
3.4. Raw Materials Sources Analysis of Global Plasma Therapy Major Manufacturers in 2019

CHAPTER 4. PLASMA THERAPY MARKET BY SOURCE
4.1. Global Plasma Therapy Revenue By Source
4.2. Allogenic
   4.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   4.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.3. Autologous
   4.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   4.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)

CHAPTER 5. PLASMA THERAPY MARKET BY TYPE
5.1. Global Plasma Therapy Revenue By Type
5.2. Leukocyte-Rich Fibrin
   5.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   5.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
5.3. Pure Platelet-Rich Fibrin
   5.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   5.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
5.4. Leukocyte-Rich Prp
   5.4.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   5.4.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
5.5. Pure Prp
   5.5.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   5.5.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)

CHAPTER 6. PLASMA THERAPY MARKET BY APPLICATION
6.1. Global Plasma Therapy Revenue By Application
6.2. Orthopaedics
   6.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   6.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
   6.2.3. Arthiritis
   6.2.4. Bone Repair and Regeneration
   6.2.5. Chronic Tendinitis
6.3. Cardiac Muscle Injury
   6.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   6.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
6.4. Dermatology
   6.4.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   6.4.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
   6.4.3. Androgenic Alopecia
   6.4.4. Plastic Surgery
   6.4.5. Dental
6.5. Nerve Injury
   6.5.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   6.5.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
6.6. Others
   6.6.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   6.6.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)

CHAPTER 7. PLASMA THERAPY MARKET BY END USER
7.1. Global Plasma Therapy Revenue By End USer
7.2. Hospitals and Clinics
   7.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   7.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
7.3. Research Institutes
   7.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   7.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
7.4. Others
   7.4.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
   7.4.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)

CHAPTER 8. NORTH AMERICA PLASMA THERAPY MARKET BY COUNTRY
8.1. North America Plasma Therapy Market Revenue and Growth Rate, 2020 - 2027 ($Million)
8.2. North America Plasma Therapy Market Revenue Share Comparison, 2020 & 2027 (%)
8.3. U.S.
   8.3.1. U.S. Plasma Therapy Market Revenue and Forecast By Source, 2020 - 2027 ($Million)
   8.3.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   8.3.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
   8.3.4. Market Revenue and Forecast By End USer, 2020 - 2027 ($Million)
8.4. Canada
   8.4.1. Market Revenue and Forecast By Source, 2020 - 2027 ($Million)
   8.4.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   8.4.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
   8.4.4. Market Revenue and Forecast By End USer, 2020 - 2027 ($Million)

CHAPTER 9. EUROPE PLASMA THERAPY MARKET BY COUNTRY
9.1. Europe Plasma Therapy Market Revenue and Growth Rate, 2020 - 2027 ($Million)
9.2. Europe Plasma Therapy Market Revenue Share Comparison, 2020 & 2027 (%)
9.3. UK
   9.3.1. Market Revenue and Forecast By Source, 2020 - 2027 ($Million)
   9.3.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   9.3.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
   9.3.4. Market Revenue and Forecast By End USer, 2020 - 2027 ($Million)
9.4. Germany
   9.4.1. Market Revenue and Forecast By Source, 2020 - 2027 ($Million)
   9.4.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   9.4.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
   9.4.4. Market Revenue and Forecast By End USer, 2020 - 2027 ($Million)
9.5. France
   9.5.1. Market Revenue and Forecast By Source, 2020 - 2027 ($Million)
   9.5.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   9.5.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
   9.5.4. Market Revenue and Forecast By End USer, 2020 - 2027 ($Million)
9.6. Spain
   9.6.1. Market Revenue and Forecast By Source, 2020 - 2027 ($Million)
   9.6.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   9.6.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
   9.6.4. Market Revenue and Forecast By End USer, 2020 - 2027 ($Million)
9.7. Rest of Europe
   9.7.1. Market Revenue and Forecast By Source, 2020 - 2027 ($Million)
   9.7.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   9.7.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
   9.7.4. Market Revenue and Forecast By End USer, 2020 - 2027 ($Million)

CHAPTER 10. ASIA-PACIFIC PLASMA THERAPY MARKET BY COUNTRY
10.1. Asia-Pacific Plasma Therapy Market Revenue and Growth Rate, 2020 - 2027 ($Million)
10.2. Asia-Pacific Plasma Therapy Market Revenue Share Comparison, 2020 & 2027 (%)
10.3. China
   10.3.1. Market Revenue and Forecast By Source, 2020 - 2027 ($Million)
   10.3.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   10.3.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
   10.3.4. Market Revenue and Forecast By End USer, 2020 - 2027 ($Million)
10.4. Japan
   10.4.1. Market Revenue and Forecast By Source, 2020 - 2027 ($Million)
   10.4.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   10.4.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
   10.4.4. Market Revenue and Forecast By End USer, 2020 - 2027 ($Million)
10.5. India
   10.5.1. Market Revenue and Forecast By Source, 2020 - 2027 ($Million)
   10.5.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   10.5.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
   10.5.4. Market Revenue and Forecast By End USer, 2020 - 2027 ($Million)
10.6. Australia
   10.6.1. Market Revenue and Forecast By Source, 2020 - 2027 ($Million)
   10.6.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   10.6.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
   10.6.4. Market Revenue and Forecast By End USer, 2020 - 2027 ($Million)
10.7. South Korea
   10.7.1. Market Revenue and Forecast By Source, 2020 - 2027 ($Million)
   10.7.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   10.7.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
   10.7.4. Market Revenue and Forecast By End USer, 2020 - 2027 ($Million)
10.8. Rest of Asia-Pacific
   10.8.1. Market Revenue and Forecast By Source, 2020 - 2027 ($Million)
   10.8.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   10.8.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
   10.8.4. Market Revenue and Forecast By End USer, 2020 - 2027 ($Million)

CHAPTER 11. LATIN AMERICA PLASMA THERAPY MARKET BY COUNTRY
11.1. Latin America Plasma Therapy Market Revenue and Growth Rate, 2020 - 2027 ($Million)
11.2. Latin America Plasma Therapy Market Revenue Share Comparison, 2020 & 2027 (%)
11.3. Brazil
   11.3.1. Market Revenue and Forecast By Source, 2020 - 2027 ($Million)
   11.3.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   11.3.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
   11.3.4. Market Revenue and Forecast By End USer, 2020 - 2027 ($Million)
11.4. Mexico
   11.4.1. Market Revenue and Forecast By Source, 2020 - 2027 ($Million)
   11.4.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   11.4.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
   11.4.4. Market Revenue and Forecast By End USer, 2020 - 2027 ($Million)
11.5. Rest of Latin America
   11.5.1. Market Revenue and Forecast By Source, 2020 - 2027 ($Million)
   11.5.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   11.5.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
   11.5.4. Market Revenue and Forecast By End USer, 2020 - 2027 ($Million)

CHAPTER 12. MIDDLE EAST & AFRICA PLASMA THERAPY MARKET BY COUNTRY
12.1. Middle East & Africa Plasma Therapy Market Revenue and Growth Rate, 2020 - 2027 ($Million)
12.2. Middle East & Africa Plasma Therapy Market Revenue Share Comparison, 2020 & 2027 (%)
12.3. GCC
   12.3.1. Market Revenue and Forecast By Source, 2020 - 2027 ($Million)
   12.3.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   12.3.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
   12.3.4. Market Revenue and Forecast By End USer, 2020 - 2027 ($Million)
12.4. South Africa
   12.4.1. Market Revenue and Forecast By Source, 2020 - 2027 ($Million)
   12.4.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   12.4.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
   12.4.4. Market Revenue and Forecast By End USer, 2020 - 2027 ($Million)
12.5. Rest of Middle East & Africa
   12.5.1. Market Revenue and Forecast By Source, 2020 - 2027 ($Million)
   12.5.2. Market Revenue and Forecast By Type, 2020 - 2027 ($Million)
   12.5.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
   12.5.4. Market Revenue and Forecast By End USer, 2020 - 2027 ($Million)

CHAPTER 13. COMPANY PROFILE
13.1. Bio Products Laboratory Ltd.
   13.1.1. Company Snapshot
   13.1.2. Overview
   13.1.3. Financial Overview
   13.1.4. Type Portfolio
   13.1.5. Key Developments
   13.1.6. Strategies
13.2. Cambryn Biologics LLC
   13.2.1. Company Snapshot
   13.2.2. Overview
   13.2.3. Financial Overview
   13.2.4. Type Portfolio
   13.2.5. Key Developments
   13.2.6. Strategies
13.3. Kedrion S.p.A.
   13.3.1. Company Snapshot
   13.3.2. Overview
   13.3.3. Financial Overview
   13.3.4. Type Portfolio
   13.3.5. Key Developments
   13.3.6. Strategies
13.4. Octapharma
   13.4.1. Company Snapshot
   13.4.2. Overview
   13.4.3. Financial Overview
   13.4.4. Type Portfolio
   13.4.5. Key Developments
   13.4.6. Strategies
13.5. CSL Ltd
   13.5.1. Company Snapshot
   13.5.2. Overview
   13.5.3. Financial Overview
   13.5.4. Type Portfolio
   13.5.5. Key Developments
   13.5.6. Strategies
13.6. China Biologic Products, Inc.
   13.6.1. Company Snapshot
   13.6.2. Overview
   13.6.3. Financial Overview
   13.6.4. Type Portfolio
   13.6.5. Key Developments
   13.6.6. Strategies
13.7. BioLife Plasma Services
   13.7.1. Company Snapshot
   13.7.2. Overview
   13.7.3. Financial Overview
   13.7.4. Type Portfolio
   13.7.5. Key Developments
   13.7.6. Strategies
13.8. LFB S.A.
   13.8.1. Company Snapshot
   13.8.2. Overview
   13.8.3. Financial Overview
   13.8.4. Type Portfolio
   13.8.5. Key Developments
   13.8.6. Strategies
13.9. Grifols International S.A.
   13.9.1. Company Snapshot
   13.9.2. Overview
   13.9.3. Financial Overview
   13.9.4. Type Portfolio
   13.9.5. Key Developments
   13.9.6. Strategies
13.10. Others
   13.10.1. Company Snapshot
   13.10.2. Overview
   13.10.3. Financial Overview
   13.10.4. Type Portfolio
   13.10.5. Key Developments
   13.10.6. Strategies

CHAPTER 14. RESEARCH APPROACH
14.1. Research Methodology
   14.1.1. Initial Data Search
   14.1.2. Secondary Research
   14.1.3. Primary Research
14.2. Assumptions and Scope

Cart Summary